Vaccination of Mice with Listeria ivanovii Expressing the Truncated M Protein of Porcine Reproductive and Respiratory Syndrome Virus Induces both Antigen-Specific CD4+ and CD8+ T Cell-Mediated Immunity.
Animals
CD4-Positive T-Lymphocytes
/ immunology
CD8-Positive T-Lymphocytes
/ immunology
Female
Immunity, Cellular
Listeria
Mice
Mice, Inbred C57BL
Porcine Reproductive and Respiratory Syndrome
/ immunology
Porcine respiratory and reproductive syndrome virus
Swine
Viral Matrix Proteins
/ immunology
Viral Vaccines
/ immunology
Listeria
Porcine reproductive and respiratory syndrome virus
Vaccine
Journal
Journal of molecular microbiology and biotechnology
ISSN: 1660-2412
Titre abrégé: J Mol Microbiol Biotechnol
Pays: Switzerland
ID NLM: 100892561
Informations de publication
Date de publication:
2019
2019
Historique:
received:
19
06
2019
accepted:
18
02
2020
pubmed:
15
4
2020
medline:
15
4
2020
entrez:
15
4
2020
Statut:
ppublish
Résumé
Porcine reproductive and respiratory syndrome (PRRS), a serious disease of swine caused by the PRRS virus (PRRSV), had a severe economic impact worldwide. As commonly used PRRS vaccines, the attenuated or inactivated vaccines, provide unsatisfactory immune protection, a new PRRS vaccine is urgently needed. In this study, a part of the PRRSV ORF6 gene (from 253 to 519 bp) encoding the hydrophilic domain of PRRSV M protein was integrated into two Listeria strains via homologous recombination to generate two PRRS vaccine candidates, namely LI-M' and LM-ΔactAplcB-M'. Both candidate vaccines showed similar growth rate as their parent strains in culture media, but presented different bacterial loads in target organs. As the integrated heterogenous gene was not expressed, LM-ΔactAplcB-M' was excluded from the immunological test. In a mouse model, LI-M' provoked both CD4+ and CD8+ T cell-mediated immunity. In addition, LI-M' boosting dramatically enhanced CD8+ T cell-mediated immunity without affecting the response intensity of CD4+ T cell-mediated immunity. All of these data suggest that LI-M' is a promising PRRS vaccine candidate.
Identifiants
pubmed: 32289779
pii: 000506686
doi: 10.1159/000506686
doi:
Substances chimiques
M protein, porcine reproductive and respiratory syndrome virus
0
Viral Matrix Proteins
0
Viral Vaccines
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
74-82Informations de copyright
© 2020 S. Karger AG, Basel.